Disease Info Card

Mitochondrial Dna Deletion

Information about Mitochondrial Dna Deletion: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Mitochondrial Dna Deletion

Most recent studies have shown that Mitochondrial Dna Deletion shares some biological mechanisms with acidosis, anemia, ataxia, blepharoptosis, cardiomyopathies, chronic-progressive-external-ophthalmoplegia, diabetes-mellitus, external-ophthalmoplegia, kearns-sayre-syndrome, malignant-neoplasms, mitochondrial-diseases, mitochondrial-encephalomyopathies, mitochondrial-myopathies, myopathy, ophthalmoplegia, pancreatic-diseases, pearsons-syndrome, retinitis-pigmentosa, sideroblastic-anemia, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Mitochondrial Dna Deletion, and have been seen in publications frequently: Aging, Cardiac Conduction, Cell Death, Cellular Senescence, Dna Replication, Electron Transport, Electron Transport Chain, Fertilization, Glucose Homeostasis, Glycolysis, Localization, Mitochondrial Dna Replication, Mitochondrial Translation, Oxidative Phosphorylation, Pathogenesis, Platelet Aggregation, Replicative Senescence, Senescence, Translation, Transport

Quite a number of genes have been found to play important roles in Mitochondrial Dna Deletion, such as APP, CDKN1A, CLU, COX5A, COX8A, CPOX, CYCS, GLB1, GSTM1, INS, POLG, SDS, SOD1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.